Detalles de la búsqueda
1.
Reconstitution of EBV-directed T cell immunity by adoptive transfer of peptide-stimulated T cells in a patient after allogeneic stem cell transplantation for AITL.
PLoS Pathog
; 18(4): e1010206, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35452490
2.
Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data.
Eur J Haematol
; 112(2): 301-309, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37830403
3.
Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-up.
Haematologica
; 108(7): 1817-1826, 2023 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36727396
4.
Impact of age on hospitalization and outcomes post allogeneic hematopoietic cell transplantation outcome, a single center experience.
Ann Hematol
; 102(4): 917-926, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36820907
5.
Influence of conditioning regimen intensity on outcomes post-allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remission.
Eur J Haematol
; 111(4): 553-561, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37461810
6.
Prognostic implication of pre-transplant FEV1 on long-term outcomes following allogeneic hematopoietic stem cell transplantation.
Eur J Haematol
; 111(5): 687-696, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37491877
7.
Weight loss post-allogeneic stem cell transplant is associated with increased transplant-related mortality.
Support Care Cancer
; 31(10): 564, 2023 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37676349
8.
Rapid single-cell identification of Epstein-Barr virus-specific T-cell receptors for cellular therapy.
Cytotherapy
; 24(8): 818-826, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35525797
9.
Allogeneic hematopoietic stem cell transplantation in patients with therapy-related hematologic malignancies developing after multiple myeloma.
Eur J Haematol
; 108(5): 430-436, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35100661
10.
Anti-thymocyte globulin and post-transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts.
Eur J Haematol
; 108(1): 61-72, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34606661
11.
Anti-thymocyte Globulin and Post-Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen-A and -B mismatched donors.
Eur J Haematol
; 108(4): 288-297, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34905239
12.
Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Cancer
; 127(2): 209-218, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33119152
13.
Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantation.
Ann Hematol
; 100(5): 1311-1319, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33710366
14.
Refined hepatic grading system in chronic graft-versus-host disease improves prognostic risk stratification of long-term outcomes.
Eur J Haematol
; 106(4): 508-519, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33421199
15.
Prolactin, a potential biomarker for chronic GVHD activity.
Eur J Haematol
; 106(2): 158-164, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33047394
16.
Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplant.
Eur J Haematol
; 106(1): 32-39, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32599663
17.
Pretransplant bone marrow cellularity and blood count recovery are not associated with relapse or survival risk following allogeneic stem cell transplant for AML in CR.
Eur J Haematol
; 107(3): 354-363, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34076909
18.
Less Is More: Superior Graft-versus-Host Disease-Free/Relapse-Free Survival with Reduced-Intensity Conditioning and Dual T Cell Depletion in Acute Myelogenous Leukemia.
Biol Blood Marrow Transplant
; 26(8): 1511-1519, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32422253
19.
Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation.
Antimicrob Agents Chemother
; 64(4)2020 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32015031
20.
Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland.
Biol Blood Marrow Transplant
; 25(7): 1450-1455, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30876928